Heteroaryl compounds useful as MK2 inhibitors
US11124525B2 · kind B2 · utility
5Cited by
8References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2018 |
| Grant date | Sep 21, 2021 |
| Priority date | — |
| Expiry date | Mar 15, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.